Dr. Thomas E. Rembetski, MD

Dr. Rembetski practices at Sage Surgical & Neuromodulation - Reno in Reno, Nevada.

Dr. Rembetski's NPI, 1942290382, was assigned on October 26, 2005. Dr. Rembetski graduated from Boston University School Of Medicine in 1977. Dr. Rembetski holds Nevada license 5964.

Dr. Rembetski's primary practice is Sage Surgical & Neuromodulation - Reno, at 5500 Reno Corporate Dr Suite 200, Reno, NV 89521. The practice phone is (775) 829-7999.

Dr. Rembetski's primary practice is Sage Surgical & Neuromodulation - Reno in Reno, Nevada. Dr. Rembetski is also affiliated with Renown Regional Medical Center. The medical group on file is Nevada Surgical Associates. Dmand AI also links Dr. Rembetski to 3 more hospitals and 1 ambulatory surgery center, each named with a free account. Dr. Rembetski's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rembetski practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Rembetski's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Rembetski is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Rembetski's licenses on file in 7 states: Nevada, Oregon, California, Colorado, Idaho, Michigan and New York.

Dmand AI lists carotid revascularization, chronic skin ulcer, leg revascularization and peripheral vascular disease among the conditions Dr. Rembetski treats.

CMS data shows 125 Medicare services from Dr. Rembetski across 5 procedure codes in 2024, for 134 Medicare patients. Medicare paid $12,898 for them.

CMS counts 134 Medicare patients who saw Dr. Rembetski in 2024. The largest group is 75 to 84, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rembetski's median patient age at 58, with 49% women.

In 2024, Dr. Rembetski wrote 73 Medicare Part D claims for 42 patients. 97% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $134 in total drug cost. In 2022, CMS named 26 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Rembetski for performance year 2024, reported through an alternative payment model (APM). Dr. Rembetski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of spinal fusion by Dr. Rembetski, more than 32% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 65 general payments to Dr. Rembetski from 23 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Medtronic USA, Inc. paid the most, $369.

Dr. Rembetski graduated from Boston University School Of Medicine in 1977.

Dr. Rembetski is in network with 12 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.